NYSE · Drug Manufacturers - Specialty & Generic

RDY (RDY) Stock

$11.69 -0.72% NYSE: RDY Healthcare

Valuation

MetricValue
Price$11.69
Market Cap$9.73B
P/E Ratio0.25
P/B Ratio0.03
P/S Ratio3.31
EPS (TTM)$53.92
52-Week High$15.71
52-Week Low$11.38
Dividend Yield0.60%

Financials & Margins

MetricValue
ROE12.20%
ROA7.94%
ROCE13.10%
Gross Margin13.83%
Operating Margin13.83%
Net Margin12.76%
Debt/Equity0.21
Current Ratio1.80

Annual Financials (USD)

Metric20222023202420252026
Revenue$214.4B$245.9B$279.2B$325.5B$353.5B
Operating Profit$29.5B$57.1B$67.7B$71.8B$48.9B
Net Profit$23.6B$45.1B$55.7B$56.5B$45.1B
EPS$28.34$54.17$66.80$67.77$53.92
Op Margin13.8%23.2%24.3%22.1%13.8%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$292.8B$321.9B$387.5B$493.0B$567.9B
Total Liabilities$102.3B$90.9B$107.0B$155.8B$195.0B
Cash$14.9B$5.8B$7.1B$14.7B$15.1B
Borrowings$33.8B$13.5B$20.0B$46.8B$75.8B

Latest News

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading MT Newswires · Jul 10, 2026 Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading MT Newswires · Jul 9, 2026 Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading MT Newswires · Jul 7, 2026 Asian Equities Traded in the US as American Depositary Receipts Soar in Monday Trading MT Newswires · Jul 6, 2026 Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading MT Newswires · Jul 1, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$28.1B$58.9B$45.4B$46.4B$56.6B
Investing Cash Flow$-45.4B$-60.2B$-67.7B$-92.5B$-95.1B
Financing Cash Flow$-1.3B$-1.9B$-2.3B$2.2B$-1.3B
Net Cash Flow$32.0M$-9.1B$1.3B$7.5B$-876.0M
Free Cash Flow$9.1B$40.0B$18.0B$12.0B$32.1B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA1.02
FCF Yield2.14%
Quick Ratio1.35
Interest Coverage12.43
Return 1Y-13.14%
Return 3Y-1.25%
Return 5Y-9.11%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMRN $60.00 -0.04% 41.31 $11.60B 0.00%
EHC $116.68 +2.45% 18.97 $11.57B 0.71%
ELAN $25.69 -2.58% -42.77 $12.83B 0.00%
ENSG $181.35 +1.84% 25.83 $10.60B 0.16%
EXELExelixis, Inc. $55.96 +0.27% 16.38 $14.07B 0.00%

About RDY

RDY is led by CEO Erez Israeli, employs 27,527 people, headquartered in Hyderabad, IN, publicly traded since 2001.

RDY stock trades at $11.69 with a market capitalization of $9.73B. The stock is valued at a price-to-earnings (P/E) ratio of 0.25, price-to-book of 0.03, price-to-sales of 3.31. Over the past 52 weeks the stock has ranged between $11.38 and $15.71, and currently trades 25.6% below its 52-week high. It pays a dividend yielding 0.60%.

On profitability, RDY generates a return on equity (ROE) of 12.20%, above the typical market average, return on capital employed of 13.10%, an operating margin of 13.83%, a net profit margin of 12.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides